Hypermobility is excess (hyper) movement (mobility) present in the joints of the human body. This is the opposite of hypomobility, the decrease of movement in the joint. Many disorders and diseases diagnosed and managed by Rheumatologists involve hypomobility - the most common being Arthritis. However, some Rheumatologists are also skilled at managing hypermobility conditions.
Few people know that hypermobility, or this extra movement at the joints, can cause widespread problems for the individual who has inherited this condition. The hypermobile nature of joints can be caused by a range of factors, including the shape of bones and bony articulations, or a training effect. However, it is important to realise that many people with hypermobility actually have problems due to the makeup of the collagen in their bodies.
Collagen is "an insoluble fibrous protein of vertebrates that is the chief constituent of the fibrils of connective tissue (as in skin and tendons)". The fact that collagen is what makes up connective tissues is how and why we often call hypermobility a 'connective tissue dysplasia.' The term 'connective tissue dysplasia' (CTD) is used as an inclusive term for over 600 disorders involving problematic connective tissue, including: The Ehlers-Danlos Syndromes, Marfan Syndrome, Loeys-Dietz Syndrome, Osteogenesis Imperfecta (OI), Arthrogryposis, and skeletal bone dysplasias.
The Spectrum of Hypermobility
Many people in the world have some level of hypermobility, either caused by bone shape, training/exercise, or through inherited connective tissue disorders. When you mention the word "hypermobility", you will often get one of these common responses:
* "My friend/daughter/sister (etc) is super flexible too - she's a dancer/gymnast/musician"
* "I'm hypermobile too - I roll my ankles and get a sore back"
* "What's that?"
* "Oh, isn't that a good thing?"
* "I wish I could do that!"
These reactions can be frustrating for people who have significant hypermobility, especially when it is quite disabling and and causes both acute and chronic pain. It is best to remember that there is a spectrum of hypermobility, from mild to extreme; you can have hypermobility in one joint, or all your joints; you can have hypermobility, or you can have hypermobility syndrome. There are many variations, making it hard to compare the impacts of being hypermobile.
Health professionals will use the Beighton Scale to get an indication of how widespread a person's hypermobility is, and often this gives an impression of how significant / problematic it is too. However, you can have a high Beighton Score and not have symptoms (e.g. pain, fatigue, dislocations) - for reasons we are still discovering.
In 2017, we are working with the new classification system decided upon by the International Consortium on the Ehlers-Danlos Syndromes.
That new classification brings with in a review of the hypermobility disorders, with hypermobility syndrome now renamed, and falling under the umbrella of Hypermobility Spectrum Disorders. This spectrum of joint hypermobility now includes:
- Asymptomatic Generalised Joint Hypermobility
- Asymptomatic Peripheral Joint Hypermobility
- Asymptomatic Localized Joint Hypermobility
- Generalised Hypermobility Spectrum Disorder
- Peripheral Hypermobility Spectrum Disorder
- Localized Hypermobility Spectrum Disorder
- Historical Hypermobility Spectrum Disorder
Taken from: A framework for the classification of joint hypermobility and related conditions (Castori et al, 2017)
- Generalized (joint) HSD (G-HSD): GJH objectively assessed (e.g., by the Beighton score) plus one or more secondary musculoskeletal manifestations as previously identified. In these patients, the pattern and severity of the involvement of the musculoskeletal system should be carefully assessed in order to explore the possibility of a full-blown hEDS. In this category usually fall most patients with GJH and additional musculoskeletal manifestations but do not meet the full diagnostic criteria for hEDS.
- Peripheral (joint) HSD (P-HSD): JH limited to hands and feet plus one or more secondary musculoskeletal manifestations as previously identified.
- Localized (joint) HSD (L-HSD): JH at single joints or group of joints plus one or more secondary musculoskeletal manifestations regionally related to the hypermobile joint(s).
- Historical (joint) HSD (H-HSD): self-reported (historical) GJH (e.g., by the five-point questionnaire) with negative Beighton score plus one or more secondary musculoskeletal manifestations as previously identified; in these cases, physical examination aimed at excluding the alternative diagnoses of G-HSD, P-HSD, and L-HSD as well as other rheumatologic conditions is mandatory.
- Joint Hypermobility (JH) is characterised by an excessive range of movement at a joint in the body.
- You can have asymptomatic joint hypermobility, that is, hypermobility in the joints which do not cause an musculoskeletal complaints.
- Hypermobility Spectrum Disorders is the term that encompasses Generalised, Peripheral, Localised and Historical Hypermobility Spectrum Disorders.
- The Beighton Scale is used to determine level of generalised hypermobility. Otherwise, in individuals whose ability to perform the Beighton Scale, the Five-Point Questionnaire is used.
- There are a range of different conditions which can cause hypermobility of the joints, of which Hypermobility Spectrum Disorders and Hypermobile EDS are just two.
THE EHLERS-DANLOS SYNDROMES
As a result of the International EDS Symposium in 2016, we now have new diagnostic criteria for the Ehlers-Danlos Syndromes. There are now 13 types of Ehlers-Danlos Syndrome, giving rise to the change in terminology to 'The Ehlers-Danlos Syndromes'.
Not all types of Ehlers-Danlos Syndrome have generalised joint hypermobility (GJH) as a major feature. Types are marked with *major or *minor to indicate importance of hypermobility in criteria.
Classical EDS (cEDS) *major
Genetic Basis: Major: COL5A1, COL5A1; Rare: COL1A1
Protein: Type V Collagen, Type I Collagen
Classic-like EDS (clEDS) *major
Genetic Basis: TNXB
Protein: Tenascin XB
Cardiac-valvular (cvEDS) *major
Genetic Basis: COL1A2 (biallelic mutations that lead to COL1A2 NMD and absence of pro α2(I) collagen chains)
Protein: Type I Collagen
Vascular EDS (vEDS) *minor
Genetic Basis: Major: COL3A1; Rare: COL1A1
Protein: (major) Type III Collagen; (rare) Type I Collagen
Hypermobile EDS (hEDS) *major
Genetic Basis: Unknown
Arthrochalasia EDS (aEDS) *major
Genetic Basis: COL1A1, COL1A2
Protein: Type I Collagen
Dermatosparaxis EDS (dEds) *minor
Genetic Basis: ADAMTS2
Kyphoscoliotic EDS (kEDS) *major
Genetic Basis: PLOD1 ; FKBP14
Protein: LH1 ; FKBP22
Brittle Cornea syndrome (BCS) *minor
Genetic Basis: ZNF469
Spondylodysplastic EDS (spEDS) *minor
Genetic Basis: B4GALT7 ; B3GALT6 ; SLC39A13
Protein: β4GalT7 ; β3GalT6 ; ZIP13
Musculocontractural EDS (mcEDS)
Genetic Basis: CHST14 ; DSE
Protein: D4ST1 ; DSE
Myopathic EDS (mEDS) *major
Genetic Basis: COL12A1
Protein: Type XII Collagen
Periodontal EDS (pEDS) *minor
Genetic Basis: C1R ; C1S
Protein: C1r; C1s
Loeys-Dietz syndrome is a disorder that affects the connective tissue in many parts of the body. Connective tissue provides strength and flexibility to structures such as bones, ligaments, muscles, and blood vessels.
There are three types of Loeys-Dietz syndrome, which are distinguished by their signs and symptoms.
TYPE I: Loeys-Dietz syndrome type I is characterized by enlargement of the aorta, which is the large blood vessel that distributes blood from the heart to the rest of the body. The aorta can weaken and stretch, causing a bulge in the blood vessel wall (an aneurysm). Stretching of the aorta may also lead to a sudden tearing of the layers in the aortic wall (aortic dissection).
People with Loeys-Dietz Syndrome Type I may have other kinds of heart defects. These individuals can also have aneurysms or dissections in arteries throughout the body and have arteries with abnormal twists and turns (arterial tortuosity). Other characteristic features of Loeys-Dietz syndrome type I include widely spaced eyes (hypertelorism), a split in the soft flap of tissue that hangs from the back of the mouth (bifid uvula), and an opening in the roof of the mouth (cleft palate). People with this condition may bruise easily and develop abnormal scars after wound healing. Affected individuals may also have skeletal problems including premature fusion of the skull bones (craniosynostosis), an abnormal side-to-side curvature of the spine (scoliosis), either a sunken chest (pectus excavatum) or a protruding chest (pectus carinatum), an inward- and upward-turning foot (clubfoot), or elongated limbs with joint deformities (contractures), that restrict the movement of certain joints.
TYPE II: Loeys-Dietz syndrome type II has features that overlap with those of type I, such as enlargement of the aorta and other arteries and arterial tortuosity. But other features of type I, such as skeletal signs, are typically less severe or absent in type II. People with Loeys-Dietz syndrome type II have skin abnormalities, such as velvety skin that is sometimes described as translucent, often with the underlying veins visible. As in type I, people with type II bruise easily and have abnormal scarring.
TYPE III: The main features of Loeys-Dietz syndrome type III are aortic and arterial aneurysms and dissections, along with joint pain (osteoarthritis) that typically becomes apparent in early to mid-adulthood. The joints most commonly affected are the joints of the hands, wrists, knees, and spine.
Because of these characteristic features, Loeys-Dietz syndrome type III is sometimes referred to as aneurysm-osteoarthritis syndrome. Other signs and symptoms of Loeys-Dietz syndrome type III include the breakdown (degeneration) of the discs that separate the bones of the spine (vertebrae) from each other, scoliosis, and flat feet (pes planus). People with type III can also have skeletal, facial, and skin features that overlap with those of Loeys-Dietz syndrome types I and II.
TYPE IV: See OMIM #614816
TYPE V: See OMIM #615582
The signs and symptoms of all types of Loeys-Dietz syndrome can become apparent anytime from childhood into adulthood. The aorta problems associated with Loeys-Dietz syndrome can be fatal by mid to late adulthood.
This information was taken directly from The Marfan Foundation
People are born with Marfan syndrome and related disorders, but they may not notice any features until later in life. However, features of Marfan syndrome and related disorders can appear at any age. Some people have many features at birth or as young children. Other people develop features, including aortic enlargement, as teens or even as adults. Some features are progressive, meaning they can get worse as people age.
All of this makes it very important for people with Marfan syndrome and related disorders to have ongoing monitoring, especially for life-threatening aspects of the condition like aortic enlargement. An accurate and early diagnosis helps to ensure proper treatment. Some treatments can prevent symptoms from getting worse and ultimately save lives.
- Long arms, legs, and fingers
- Tall and thin body type
- Curved spine
- Chest sinks in or sticks out
- Flexible joints
- Flat feet
- Crowded teeth
- Stretch marks on the skin that are not related to weight gain or loss
Other signs are harder to detect
Harder-to-detect signs of Marfan syndrome include heart problems, especially those related to the aorta, the large blood vessel that carries blood away from the heart to the rest of the body. Other signs can include sudden lung collapse and eye problems, including severe nearsightedness, dislocated lens, detached retina, early glaucoma, and early cataracts. Special tests are often needed to detect these features.